标准股骨柄初次金属对聚乙烯全髋关节置换术后因症状性假性肿瘤行翻修术
该研究纳入1999年至2016年5月期间接受初次全髋关节置换术的2102例患者共2446髋,均使用同一非骨水泥、非组配颈股骨柄及金属对聚乙烯或陶瓷对聚乙烯摩擦界面。因症状性假性肿瘤行翻修术的患病率为0.5%(13例),平均随访7年,发病率为0.9例/1000人年,13例翻修全部见于金属对聚乙烯界面患者。
要点
- 非金属对金属全髋关节置换术后因症状性假性肿瘤翻修的患病率为0.5%(13例)。
- 平均随访7年,发病率为0.9例/1000人年。
- 13例翻修全部发生在金属对聚乙烯界面患者中。
核心结论
- 在非金属对金属全髋关节置换术队列中,因症状性假性肿瘤形成而行翻修术的患病率为0.5%。
- 作者指出,即使标准金属对聚乙烯全髋关节置换术后,需翻修手术的症状性假性肿瘤形成也是确实存在的并发症。
研究设计与样本
- 前瞻性观察性队列研究,纳入1999年至2016年5月期间接受初次全髋关节置换术的2102例患者共2446髋。
- 所有患者均使用同一非骨水泥、非组配颈股骨柄及金属对聚乙烯(n=2409)或陶瓷对聚乙烯(n=37)摩擦界面。
- 通过手术与病历回顾、随访 visits 及瑞典髋关节置换登记库进行随访。
- 采用金属伪影减少序列磁共振成像(MARS MRI)诊断假性肿瘤,并对所有因假性肿瘤行翻修的患者测量血清金属离子水平和炎症标志物水平。
主要发现
- 因症状性假性肿瘤形成行翻修术的患病率为0.5%(13例),平均随访时间7年。
- 发病率为0.9例/1000人年。
- 全部13例翻修均发生于金属对聚乙烯界面患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pseudotumor formation following total hip arthroplasty (THA) is a well-known complication mainly associated with metal-on-metal (MoM) bearings and taper corrosion on modular-neck femoral stems. The purpose of this study was to determine the prevalence of revision surgery for symptomatic pseudotumors in a large cohort of patients treated with primary THA with a standard stem and a non-MoM articulation. METHODS: We included 2,102 patients treated with a total of 2,446 THAs from 1999 until May 2016 in a prospective, observational cohort study. All patients underwent THA with the same uncemented, non-modular-neck femoral stem and metal-on-polyethylene (MoP) (n = 2,409) or ceramic-on-polyethylene (n = 37) articulation. All patients were followed by means of a combination of surgical and medical chart review, follow-up visits, and the Swedish Hip Arthroplasty Register. Metal artifact reduction sequence magnetic resonance imaging (MARS MRI) was used for diagnosis of the pseudotumors, and serum metal ion levels and inflammatory marker levels were measured for all patients who underwent a revision due to pseudotumor. RESULTS: The prevalence of revision for symptomatic pseudotumor formation was 0.5% (13 cases) at a mean follow-up time of 7 years. The incidence rate was 0.9 case per 1,000 person-years. All 13 revisions were done in patients with an MoP articulation. CONCLUSIONS: This study demonstrated a 0.5% prevalence of revision due to symptomatic pseudotumor formation in a cohort of patients who underwent THA with a non-MoM construct. Surgeons should be aware that symptomatic pseudotumor formation requiring revision surgery is a tangible complication even after standard MoP THA. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Persson A, Eisler T, Bodén H, et al. Revision for Symptomatic Pseudotumor After Primary Metal-on-Polyethylene Total Hip Arthroplasty with a Standard Femoral Stem. J Bone Joint Surg Am. 2018. PMID: 29870445. doi:10.2106/JBJS.17.00616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。